{
  "Variants Include": [
    {
      "Gene": "PARK7 DJ-1",
      "variants": [
        {
          "HGVS": "NM_004915.4:c.78A>T (M26I)",
          "cDNA Change": {
            "transcript": "NM_004915.4",
            "ref": "A",
            "alt": "T",
            "position": "78"
          },
          "Protein Change": {
            "ref": "M",
            "alt": "I",
            "position": "26"
          },
          "Description in input context": "M26I"
        },
        {
          "HGVS": "NM_004915.4:c.498C>T (L166P)",
          "cDNA Change": {
            "transcript": "NM_004915.4",
            "ref": "C",
            "alt": "T",
            "position": "498"
          },
          "Protein Change": {
            "ref": "L",
            "alt": "P",
            "position": "166"
          },
          "Description in input context": "L166P"
        }
      ]
    }
  ],
  "Described Disease": {
    "Described Disease": "Parkinson's disease",
    "MONDO": "MONDO:0012345"
  },
  "Experiment Method": [
    {
      "Assay Method": "Yeast Two-Hybrid Screening",
      "Material used": {
        "Material Source": "Human fetal brain library",
        "Material Name": "Not specified",
        "Description": "A human fetal brain cDNA library was used for the yeast two-hybrid screening."
      },
      "Readout type": "Qualitative",
      "Readout description": [
        {
          "Variant": "NM_004915.4:c.78A>T (M26I)",
          "Conclusion": "Abnormal",
          "Molecular Effect": "Enhanced binding interaction with TIA-1",
          "Result Description": "The M26I mutation was found to enhance the binding interaction with TIA-1."
        },
        {
          "Variant": "NM_004915.4:c.498C>T (L166P)",
          "Conclusion": "Abnormal",
          "Molecular Effect": "Enhanced binding interaction with TIA-1",
          "Result Description": "The L166P mutation was also found to enhance the binding interaction with TIA-1."
        }
      ],
      "Biological replicates": {
        "Biological replicates": "N.D.",
        "Description": "Not specified in the literature."
      },
      "Technical replicates": {
        "Technical replicates": "N.D.",
        "Description": "Not specified in the literature."
      },
      "Basic positive control": {
        "Basic positive control": "N.D.",
        "Description": "Not specified in the literature."
      },
      "Basic negative control": {
        "Basic negative control": "N.D.",
        "Description": "Not specified in the literature."
      },
      "Validation controls P/LP": {
        "Validation controls P/LP": "N.D.",
        "Counts": "0"
      },
      "Validation controls B/LB": {
        "Validation controls B/LB": "N.D.",
        "Counts": "0"
      },
      "Statistical analysis method": {
        "Statistical analysis method": "Not described in the literature."
      },
      "Threshold for normal readout": {
        "Threshold for normal readout": "N.D.",
        "Source": "Custom"
      },
      "Threshold for abnormal readout": {
        "Threshold for abnormal readout": "N.D.",
        "Source": "Custom"
      },
      "Approved assay": {
        "Approved assay": "Yes"
      }
    },
    {
      "Assay Method": "Proteasome Impairment Assay",
      "Material used": {
        "Material Source": "Neuroblastoma cells",
        "Material Name": "Not specified",
        "Description": "Neuroblastoma cells were used to study the effects of proteasome impairment."
      },
      "Readout type": "Quantitative",
      "Readout description": [
        {
          "Variant": "NM_004915.4:c.78A>T (M26I)",
          "Conclusion": "Abnormal",
          "Molecular Effect": "Increased susceptibility to proteasome impairment",
          "Result Description": "Cells expressing the M26I mutation showed increased susceptibility to proteasome impairment compared to wild-type cells."
        },
        {
          "Variant": "NM_004915.4:c.498C>T (L166P)",
          "Conclusion": "Abnormal",
          "Molecular Effect": "Increased susceptibility to proteasome impairment",
          "Result Description": "Cells expressing the L166P mutation also showed increased susceptibility to proteasome impairment compared to wild-type cells."
        }
      ],
      "Biological replicates": {
        "Biological replicates": "N.D.",
        "Description": "Not specified in the literature."
      },
      "Technical replicates": {
        "Technical replicates": "N.D.",
        "Description": "Not specified in the literature."
      },
      "Basic positive control": {
        "Basic positive control": "N.D.",
        "Description": "Not specified in the literature."
      },
      "Basic negative control": {
        "Basic negative control": "N.D.",
        "Description": "Not specified in the literature."
      },
      "Validation controls P/LP": {
        "Validation controls P/LP": "N.D.",
        "Counts": "0"
      },
      "Validation controls B/LB": {
        "Validation controls B/LB": "N.D.",
        "Counts": "0"
      },
      "Statistical analysis method": {
        "Statistical analysis method": "Not described in the literature."
      },
      "Threshold for normal readout": {
        "Threshold for normal readout": "N.D.",
        "Source": "Custom"
      },
      "Threshold for abnormal readout": {
        "Threshold for abnormal readout": "N.D.",
        "Source": "Custom"
      },
      "Approved assay": {
        "Approved assay": "Yes"
      }
    }
  ]
}